Articles related to Oncology, Radiation

Careful management with endocrinology expertise is crucial when considering radioligand therapy for pheochromocytomas and paragangliomas to avoid potentially life-threatening catecholamine crises.

In a phase 3 trial, tisotumab vedotin showed a median overall survival of 11.5 months compared to 9.5 months with standard chemotherapy in patients with recurrent cervical cancer, representing a 30% reduction in the risk of death.

This refined surgical technique for robotic-assisted laparoscopic radical prostatectomy focuses on preserving vital supportive structures while effectively removing the prostate, potentially enhancing post-operative outcomes.

Recent research suggests that transperineal prostate biopsies can be safely performed without antibiotics, potentially offering an alternative to traditional transrectal biopsies for cancer detection and monitoring.

This study provides concrete data on the proportion of cancer cases attributable to modifiable risk factors, offering a powerful tool for patient education and risk reduction strategies.

The pressure to publish extensively, attend numerous conferences, and navigate academic tribalism is causing young oncologists to reconsider careers in academia, potentially impacting the future of cancer research and treatment.